Exthymic Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 14

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 6

Exthymic General Information

Description

Operator of a biotechnology company intended to focus on democratizing access to autologous cell therapies through point-of-care manufacturing. The company is currently operating in Stealth mode.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3033 Science Park Road
  • Suite 250
  • San Diego, CA 92121
  • United States
+1 (717)
Primary Industry
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • 3033 Science Park Road
  • Suite 250
  • San Diego, CA 92121
  • United States
+1 (717)

Exthymic Timeline

202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Exthymic Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 01-Jan-2026 Completed Startup
2. Accelerator/Incubator 11-Mar-2025 Completed Startup
1. Early Stage VC 13-May-2024 $10.2M $10.2M Completed Startup
To view Exthymic’s complete valuation and funding history, request access »

Exthymic Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed
To view Exthymic’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Exthymic Patents

Exthymic Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026039684-A1 Systems and methods for manipulation or evaluation of a biological sample Pending 16-Aug-2024
US-10488321-B2 Devices and methods for high-throughput single cell and biomolecule analysis and retrieval in a microfluidic chip Active 19-Mar-2015
US-20180067038-A1 Devices and methods for high-throughput single cell and biomolecule analysis and retrieval in a microfluidic chip Active 19-Mar-2015

Exthymic Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Exthymic Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Hawktail Venture Capital Minority
Phase Two Ventures Venture Capital Minority
CONNECT (San Diego) Accelerator/Incubator
Alix Ventures Venture Capital Minority
Dimension (United States) Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Exthymic FAQs

  • When was Exthymic founded?

    Exthymic was founded in 2023.

  • Where is Exthymic headquartered?

    Exthymic is headquartered in San Diego, CA.

  • What is the size of Exthymic?

    Exthymic has 14 total employees.

  • What industry is Exthymic in?

    Exthymic’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Exthymic a private or public company?

    Exthymic is a Private company.

  • What is Exthymic’s current revenue?

    The current revenue for Exthymic is .

  • How much funding has Exthymic raised over time?

    Exthymic has raised $10.2M.

  • Who are Exthymic’s investors?

    Hawktail, Phase Two Ventures, CONNECT (San Diego), Alix Ventures, and Dimension (United States) are 5 of 6 investors who have invested in Exthymic.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process